Unproven Peptides, GLP1s, and Reversing America's Obesity Rate — Dr. Krishna Vedala
Dive Into Health MD
0:00 / 0:00
Unproven Peptides, GLP1s, and Reversing America's Obesity Rate — Dr. Krishna Vedala
42 просмотра · 2 недели назад
Dive Into Health MD
50 подписчиков
42 просмотра · 2 недели назад
Dr. Krishna Vedala is a board-certified internal medicine and obesity medicine physician based in Oklahoma City, with a Master of Public Health and an MBA. He is the host of the Connected by Health podcast and a passionate advocate for prevention, physician leadership, and making obesity medicine accessible to all patients.
In this episode, you'll learn:
– What peptides are and why only one is truly FDA approved
– How GLP-1s reversed the US obesity rate for the first time ever
– How dual and triple agonists differ — and which one best preserves muscle
– What labs to monitor if your patients utilize unproven peptides
– How GLP-1s are getting patients off blood pressure meds, insulin, and diabetic drugs
– Where oral formulations, pediatric prevention, and new indications are headed
Timestamp:
[00:00] Dr. Vedala's background in internal medicine, obesity medicine, public health, and why he ended up in primary care
[09:17] Peptides 101: what they are, which are FDA approved, and the difference between GLP-1s and unproven compounds like TB500, NAD+, and ipamorelin
[13:18] The US obesity rate dropped from 39% to 36% — the first reversal ever — with 11% of Americans now on a GLP-1
[16:47] Compounded GLP-3 from China, patient overdoses, and what clinicians can actually say or do
[22:19] Tapering off GLP-1s: why weight comes back without lifestyle change, and how to find the right maintenance dose
[28:18] From semaglutide to tirzepatide to retatrutide: why the glucagon receptor changes the muscle-wasting equation
[41:19] Emerging indications: autoimmune disease, alcoholism, Alzheimer's dementia, and the type 3 diabetes theory
[44:03] Getting patients off blood pressure medication, insulin, and cholesterol drugs — and why that's the actual goal
[53:34] Obesity medicine in 10 years: oral GLP-1s, pediatric prevention strategies, and the decline of injectable reliance
[58:51] How to evaluate a compounding pharmacy: ingredient sourcing, sterility protocols, and pricing red flags
Connect with Dr. Krishna Vedala:
Podcast: https://connectedbyhealthpodcast.com/
Connect with Akshita:
Instagram: @diveintohealthmd | Website: http://diveintohealthmd.com
This episode is for educational purposes only and does not constitute medical advice. Please consult your physician before making changes to your medications or health regimen.